Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production - Jung, T W; Lee, J Y; Shim, W S; Kang, E S; Kim, S K; Ahn, C W; Lee, H C; Cha, B S (J Neurol Sci, 2007)